Status | Study |
Terminated |
Study Name: Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X) Condition: Chronic Uveitis Date: 2015-02-16 Interventions: Biological: Gevokizumab |
Active, not recruiting |
Study Name: A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behcet's Disease Condition: Behcet Syndrome Date: 2014-12-02 Interventions: Drug: Apremilast (CC-10004) Ot |
Terminated |
Study Name: Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis Condition: Behcet's Disease Uveitis Date: 2014-10-02 Interventions: Drug: Placebo Solution for sub |
Terminated |
Study Name: An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data Condition: Uveitis Date: 2014-10-02 Interventions: Drug: Dose 2 gevokizumab Solution for subcutaneous injection |
Enrolling by invitation |
Study Name: VCRC Patient Contact Registry Patient-Reported Data Validation Study Condition: Behcet's Disease Churg-Strauss Syndrome Date: 2014-05-30 |
Completed |
Study Name: Educational Needs of Patients With Systemic Vasculitis Condition: Behcet's Disease Churg-Strauss Syndrome Date: 2014-05-30 |
Completed |
Study Name: Vasculitis Illness Perception (VIP) Study Condition: Wegener Granulomatosis Microscopic Polyangiitis Churg-Stra Date: 2014-05-30 |
Completed |
Study Name: Reproductive Health in Men and Women With Vasculitis Condition: Giant Cell Arteritis Takayasu's Arteritis Polyarteritis No Date: 2014-05-30 |
Recruiting |
Study Name: Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases Condition: Rheumatoid Arthritis Ankylosing Spondylitis Systemic Lupus Date: 2013-11-07 Interventions: Drug: Interleukin 2 Induction period: repeated administration of low-dose IL-2 (1MUI/day, sc) during 5 c |
Terminated |
Study Name: Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B) Condition: Behcet's Uveitis Date: 2013-09-17 Interventions: Drug: Gevokizumab Sterile solu |